课题基金 / 基金详情

TREATMENT OF SEVERE SYSTEMIC LUPUS WITH MONTHLY INTRAVENOUS CYCLOPHOSPHAMIDE

TREATMENT OF SEVERE SYSTEMIC LUPUS WITH MONTHLY INTRAVENOUS CYCLOPHOSPHAMIDE
每月静脉注射环磷酰胺治疗严重系统性狼疮
批准号:
6274575
负责人:
WILLIAM J MC CUNE
金额:
$2.15万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30

项目摘要

项目成果

WILLIAM J MC CUNE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Patients with severe systemic lupus, primarily renal or neurologic, will be treated monthly with intravenous cyclophosphamide infusions plus daily oral prednisone. At the end of six months, a decision will be made regarding satisfactory control of disease activity. Patients who are doing well will be randomized to receive either daily oral azathioprine for 30 months or intravenous cyclophosphamide every 3 months for 30 months. Minor flares will be treated with increased prednisone; major flares will be treated by restarting monthly intravenous cyclophosphamide. Patients who flare on azathioprine maintenance therapy will be switched to cyclophosphamide maintenance therapy. A new feature of this protocol will be contraception using implanted progestins ("Norplant") in all suitable female patients of child-bearing age. (In the past we have generally used either Norplant, injectable progestins or oral contraceptives for this purpose).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RCT of GnRH-a for ovarian protection during CYC therapy for rheumatic disease
EFFICACY & SAFETY OF RITUXIMAB FOR MOD TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS
ENDOTHELIAL DYSFUNCTION IN CHILDREN & ADULTS W/ SYSTEMIC LUPUS ERYTHEMATOSUS
ENDOTHELIAL DYSFUNCTION IN CHILDREN & ADULTS W/ SYSTEMIC LUPUS ERYTHEMATOSUS
海外基金